The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...
DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.
The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...
The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...
Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.
Advocacy groups, providers and virtual care companies said clinicians and pharmacies need time to comment on the rule and prepare for implementation. During the COVID-19 public health emergency, ...
The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback